rMark Bio, Inc.
SEC Form D private-offering issuer in Other Technology
rMark Bio, Inc. operates in sec form d - other technology based in CHICAGO, ILLINOIS, founded in 2015.
Profile
Private US issuer recorded in the SEC Form D structured dataset for 2018Q1. Industry: Other Technology. Revenue range: Decline to Disclose. Offering amount: 1000000.
rMark Bio, Inc. is positioned in sec form d - other technology, a segment that rewards a clear, focused offering.
CHICAGO, ILLINOIS is where the company is located.
Its current recorded stage is Regulation D.
Its team size is recorded as 11-50 employees.
Total disclosed funding stands at about $1M.
| Sector | SEC Form D - Other Technology |
|---|---|
| Headquarters | CHICAGO, ILLINOIS |
| Country | United States |
| Founded | 2015 |
| Employees | 11-50 |
| Stage | Regulation D |
| Total funding | $1,000,000 |
Website: rmarkbio.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account